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Abstract
An exposure to GB virus C/hepatitis G virus (GBV-C/HGV) was studied among populations
at risk for blood and sexual exposure to analyze risk factor of the transmission of the virus. Blood
samples were drawn from 98 intravenous drug users (IVDU), 100 female high-class commercial
sex workers (CSW) and 50 male outpatients (MOP) at a sexually transmitted diseases (STD) clinic
in Chiang Mai, Thailand. These blood samples were analyzed for GBV-C/HGV RNA; antibod-
ies against second envelope protein of GBV-C/HGV (anti-E2); anti-hepatitis C virus antibody
(HCV-Ab); hepatitis B core antibody (HBcAb); and antibodies against human immunodeficiency
virus (HIV-Ab). Prevalences of GBV-C/HGV RNA, anti-E2, HCV-Ab, HBcAb and HIV-Ab were
27.6%, 16.3%, 84.7%, 76.5% and 45.0% in IVDU; 0%, 21.5%, 2.0%, 72.0% and 11.0% in CSW;
6.0%, 13.6%, 0%, 64.0% and 14.0% in MOP. While the prevalence of GBV-C/HGV RNA was
higher in IVDU than in CSW and MOP, comparable prevalences of anti-E2 among the three popu-
lations were found. Intravenous drug injection showed association with GBV-C/HGV RNA, while
history of STD associated with anti-E2. In conclusion, intravenous drug injection and STD were
found to be risk factors for the previous exposure to GBV-C/HGV, but STD did not increase the
risk of the GBV-C/HGV viraemia.
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